ReviewJournal of clinical medicine2023

Neurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma Patients.

Prema Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.